Cargando…

Targeting the Initiator Protease of the Classical Pathway of Complement Using Fragment-Based Drug Discovery

The initiating protease of the complement classical pathway, C1r, represents an upstream and pathway-specific intervention point for complement-related autoimmune and inflammatory diseases. Yet, C1r-targeted therapeutic development is currently underrepresented relative to other complement targets....

Descripción completa

Detalles Bibliográficos
Autores principales:	Rushing, Blake R., Rohlik, Denise L., Roy, Sourav, Skaff, D. Andrew, Garcia, Brandon L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504721/ https://www.ncbi.nlm.nih.gov/pubmed/32899120 http://dx.doi.org/10.3390/molecules25174016

Ejemplares similares

Activation of the classical pathway of complement by Hageman factor fragment
Publicado: (1981)

The contribution of the alternative pathway in complement activation on cell surfaces depends on the strength of classical pathway initiation
por: de Boer, Esther CW, et al.
Publicado: (2023)

C1 fixation and classical complement pathway activation by a fragment of the Cmu4 domain of IgM
Publicado: (1975)

Conformational dynamics of complement protease C1r inhibitor proteins from Lyme disease– and relapsing fever–causing spirochetes
por: Roy, Sourav, et al.
Publicado: (2023)

Antibody-independent complement activation by myelin via the classical complement pathway
Publicado: (1982)

Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease
Publicado: (1992)

Serine Proteases in the Lectin Pathway of the Complement System
por: Andrade, Fabiana A., et al.
Publicado: (2017)

Borrelia burgdorferi BBK32 Inhibits the Classical Pathway by Blocking Activation of the C1 Complement Complex
por: Garcia, Brandon L., et al.
Publicado: (2016)

Structural determination of the complement inhibitory domain of Borrelia burgdorferi BBK32 provides insight into classical pathway complement evasion by Lyme disease spirochetes
por: Xie, Jialei, et al.
Publicado: (2019)

Unmasking of crucial structural fragments for coronavirus protease inhibitors and its implications in COVID-19 drug discovery
por: Ghosh, Kalyan, et al.
Publicado: (2021)

Continual Low-Level Activation of the Classical Complement Pathway
por: Manderson, Anthony P., et al.
Publicado: (2001)

Carbamylation of immunoglobulin abrogates activation of the classical complement pathway
por: Koro, Catalin, et al.
Publicado: (2014)

Preanalytical classical and alternative complement pathway activity loss
por: Vercauteren, Koen O.A., et al.
Publicado: (2019)

A New Tool for Complement Research: In vitro Reconstituted Human Classical Complement Pathway
por: Mutti, Michele, et al.
Publicado: (2018)

Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity
por: Gregersen, Emil, et al.
Publicado: (2021)

1000. Serotype 3 pneumococci evade activation of the classical complement pathway
por: Lapidot, Rotem, et al.
Publicado: (2021)

Safety and efficacy of classical complement pathway inhibition with sutimlimab in chronic immune thrombocytopenia
por: Broome, Catherine M., et al.
Publicado: (2022)

Discovery of inhibitors against SARS-CoV-2 main protease using fragment-based drug design
por: Shao, Hai Ping, et al.
Publicado: (2023)

Expanding horizons in complement drug discovery: challenges and emerging strategies
por: Harris, Claire L.
Publicado: (2017)

Fragments and hot spots in drug discovery
por: Vajda, Sandor, et al.
Publicado: (2015)

Reactivity of Covalent Fragments and Their Role in Fragment Based Drug Discovery
por: McAulay, Kirsten, et al.
Publicado: (2022)

Intrathecal complement activation by the classical pathway in tick-borne encephalitis
por: Veje, Malin, et al.
Publicado: (2019)

Distinct Roles of Classical and Lectin Pathways of Complement in Preeclamptic Placentae
por: Belmonte, Beatrice, et al.
Publicado: (2022)

The classical pathway triggers pathogenic complement activation in membranous nephropathy
por: Seifert, Larissa, et al.
Publicado: (2023)

Analysis of the classical, alternative, and MBL pathways of the complement system in juvenile idiopathic arthritis
por: Brunner, J, et al.
Publicado: (2008)

Complementary Roles of the Classical and Lectin Complement Pathways in the Defense against Aspergillus fumigatus
por: Rosbjerg, Anne, et al.
Publicado: (2016)

Activation of classical and alternative complement pathways in the pathogenesis of lung injury in COVID-19
por: Satyam, Abhigyan, et al.
Publicado: (2021)

Fragment-Based Lead Discovery Strategies in Antimicrobial Drug Discovery
por: Konaklieva, Monika I., et al.
Publicado: (2023)

Fragment Library of Natural Products and Compound Databases for Drug Discovery †
por: Chávez-Hernández, Ana L., et al.
Publicado: (2020)

Systemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical Pathway
por: Macedo, Ana Catarina Lunz, et al.
Publicado: (2016)

An Excretory Protein of Echinococcus multilocularis Inhibits Complement Classical Pathway Activation
por: Qiu, Yiwen, et al.
Publicado: (2022)

Fragment approaches in structure-based drug discovery
por: Hubbard, Roderick E.
Publicado: (2008)

Is it time for biocatalysis in fragment-based drug discovery?
por: Ramsden, Jeremy I., et al.
Publicado: (2020)

Using ChEMBL to Complement Schistosome Drug Discovery
por: Padalino, Gilda, et al.
Publicado: (2023)

Discovery of a metabolic alternative to the classical mevalonate pathway
por: Dellas, Nikki, et al.
Publicado: (2013)

Fragment-Sized Thiazoles in Fragment-Based Drug Discovery Campaigns: Friend or Foe?
por: Proj, Matic, et al.
Publicado: (2022)

Scabies Mite Inactive Serine Proteases Are Potent Inhibitors of the Human Complement Lectin Pathway
por: Reynolds, Simone L., et al.
Publicado: (2014)

Antiviral Drug Discovery: Norovirus Proteases and Development of Inhibitors
por: Chang, Kyeong-Ok, et al.
Publicado: (2019)

Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases
por: Lintner, Katherine E., et al.
Publicado: (2016)

Editorial: State-of-the-Art Research on C1q and the Classical Complement Pathway
por: Kishore, Uday, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bcqcknemmj3d0el0aj10rnmb80